Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Rxo (RXO) Accumulated Depreciation & Amortization (2021 - 2025)

Rxo (RXO) has disclosed Accumulated Depreciation & Amortization for 5 consecutive years, with $116.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 33.33% year-over-year to $116.0 million, compared with a TTM value of $116.0 million through Dec 2025, up 33.33%, and an annual FY2025 reading of $116.0 million, up 33.33% over the prior year.
  • Accumulated Depreciation & Amortization was $116.0 million for Q4 2025 at Rxo, up from $87.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $116.0 million in Q4 2025 and bottomed at $16.0 million in Q3 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is $72.4 million, with a median of $81.0 million recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization dropped 22.09% in 2023, then surged 237.5% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $81.0 million in 2021, then rose by 6.17% to $86.0 million in 2022, then dropped by 22.09% to $67.0 million in 2023, then grew by 29.85% to $87.0 million in 2024, then soared by 33.33% to $116.0 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for RXO at $116.0 million in Q4 2025, $87.0 million in Q4 2024, and $54.0 million in Q3 2024.